SOM-230

Known as: SOM 230, SOM230 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Pasireotide (SOM230) is a novel multireceptor-targeted somatostatin (sst) analog with high binding affinity for sst receptor… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2010
Review
2010
The incidence and prevalence of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) have increased in the past 20 years. GEP… (More)
  • figure 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cush1. ing’s syndrome. Lancet 2006;367:1605-17. de Bruin C, Pereira AM… (More)
Is this relevant?
2010
2010
CONTEXT Pituitary adenomas can cause specific syndromes due to hormone excess and/or determine sellar mass symptoms. Pituitary… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2010
2010
Somatostatin analogs that activate the somatostatin subtype 2A (sst2A) receptor are used to treat neuroendocrine cancers because… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2007
2007
Somatostatin (SRIF)-14 is recognized as an important mediator between the nervous and the immune system, although the functional… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVES Somatostatin (SST) analogues play an important role in the medical management of somatotroph pituitary adenomas and… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Functional gastroenteropancreatic tumors express all 5 somatostatin receptor subtypes (sst) in different quantities. Octreotide… (More)
Is this relevant?
Review
2004
Review
2004
More than 30 years have passed since somatostatin was discovered and its hormonal function defined. The wide range of anatomical… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
OBJECTIVE The aim of the present study was to identify a small, metabolically stable somatotropin release inhibiting factor (SRIF… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?